2 unknown. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Unknown 2 |
Follow Heart Failure NYHA Class III: new trials by email Literature Review of Heart Failure NYHA Class III trials Research Report on Heart Failure NYHA Class III
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Beneficial Effects of Vitamin D Combined With Oral Iron Supplementation in Patients With Chronic Heart Failure and Iron Deficiency Sucrosomial iron, Vitamin D, Ferric Carboxymaltose 50 MG/ML - Heart Failure, Iron-deficiency | Phase 4 | Unknown | University of Padova | 258 | 2024-01-15 | 2023-12-15 |
| Remission From Stage D Heart Failure Pharmacological Treatment - Heart Failure NYHA Class III, Heart Failure NYHA Class IV | Phase 4 | Unknown | University of Louisville | 40 | 2013-01-01 | 2017-04-27 |
Anemia, Iron-Deficiency (1) · Heart Failure (1) · Heart Failure, Systolic (1) · Iron Deficiencies (1) · Vitamin D Deficiency (1)
Anemia (1) · Anemia, Hypochromic (1) · Avitaminosis (1) · Cardiovascular Diseases (1) · Deficiency Diseases (1) · Heart Diseases (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Iron Metabolism Disorders (1) · Malnutrition (1) · Metabolic Diseases (1) · Nutrition Disorders (1) · Nutritional and Metabolic Diseases (1)
Drug Therapy (1) · Vitamin D (1) · ferric carboxymaltose (1) · sucrosomial iron (1)
University of Louisville (1) · University of Padova (1)
United States (1)
Emma Birks, MD (1) · Federico Capone, MD (1) · Roberto Vettor, MD (1)